The year's new drugsbiologics, 2017, part II - News that shaped the industry in 2017
| Autor: | Coia Dulsat, Elisabet Cruces, P. Pina, M. Tracy, Ann I. Graul |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Drug Industry
Orphan Drug Production Universal flu vaccine 01 natural sciences Drug Costs Orphan drug Mergers and acquisitions Medicine Humans Pharmacology (medical) Marketing Drug industry Drug Approval Pharmacology Biological Products 010405 organic chemistry business.industry General Medicine 0104 chemical sciences Analgesics Opioid 010404 medicinal & biomolecular chemistry Influenza Vaccines Drug Design Drug pricing business Developed country |
| Zdroj: | Drugs of today (Barcelona, Spain : 1998). 54(2) |
| ISSN: | 1699-3993 |
| Popis: | This eagle's-eye overview of the drug industry in 2017 provides insight into some of last year's top stories, including the growing opioid crisis affecting the U.S. and other developed countries and the 2017-2018 influenza epidemic, with a spotlight on the need for a universal flu vaccine. As in previous years, we also review orphan drug development, new agency-supported programs such as PRIME and RMAT, pipeline attrition and drug pricing, as well as pharma/biotech mergers and acquisitions of note. Finally, we take a glimpse into the crystal ball to anticipate the new drugs that will be approved in 2018. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|